Belgium· BE-AMP-SAM665890-00

Kerendia 40 mg

A finerenone product containing finerenone, registered in Belgium by Bayer. The same ATC class is registered in 15 of our 19 countries.

ATC C03DA05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedKerendia 40 mgATCC03DA05REGISTER NO.BE-AMP-SAM665890-00PACKS LISTED0CHECKEDSeptember 26, 2026

Where it is registered

Finerenone is registered in 15 of 19 countries.

Countries holding a registration under ATC C03DA05 (finerenone), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 9 of them publish a price we can compare per daily dose

Finerenone · ATC C03DA05

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of finerenone costs, country by country.

Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Finerenone · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • IT Italy$5.64
  • CH Switzerland$4.82
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Finerenone
Manufacturer
Bayer
Country
Belgium (BE)
ATC code
C03DA05
ATC class
Finerenone
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Finerenone in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All finerenone products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Kerendia
  • Liechtenstein · Kerendia
  • Norway · Kerendia

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f3686d56-dc24-4bf2-87a8-63f810907226
GET /v1/drugs/f3686d56-dc24-4bf2-87a8-63f810907226?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Kerendia 40 mg",
  "name_fr": "Kerendia 40 mg",
  "name_nl": "Kerendia 40 mg",
  "amp_code": "SAM665890-00",
  "strengths": [
    "40.0000",
    "40.0000",
    "25.0000"
  ],
  "pack_count": 4,
  "substances": [
    "Finerenone",
    "Lactose",
    "Sodium Laurilsulfate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Finerenone",
  "authorisation_numbers": [
    "EU/1/21/1616/011",
    "EU/1/21/1616/012",
    "EU/1/21/1616/014",
    "EU/1/21/1616/013"
  ]
}

See everything about finerenone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.